Meetings and Seminars

World Cancer Research Fund International will be launching a new grant call for 2025/26 on 8 September.
We accept research applications focusing on the role of diet, nutrition (including body composition) and physical activity in cancer prevention or cancer survivorship.
Outline application stage for both grant calls:

9:00 BST 8 September 2025
to
17:00 GMT 4 November 2025

Full application stage: January 2026 (IRC), February 2026 (RGP)
- Regular Grant Programme (RGP)
Applicants should be senior established researchers and can be based in any country outside of the Americas. In addition to our standard remit, this year we are accepting studies investigating environmental exposures relevant to cancer, provided they are ingested dietary or drinking water contaminants. More information on the eligibility and the scientific scope of the grant call is on our webpages.
- INSPIRE Research Challenge (IRC)
Applicants should be early career researchers (2-7 years post-PhD or equivalent higher research degree) and can be based anywhere in the world. In addition to our standard remit, this grant call welcomes applications investigating other modifiable exposures including stress, sleep, immune function and environmental exposures. More information can be found on our webpages.
Please ensure you read the guidelines and application form instructions carefully before applying. If you have any questions, the Research
Funding Team will be happy to help
mail research@wcrf.org (RGP)
or
inspire@wcrf.org (IRC)
to speak with one of the team

Explore the design, optimization, and use of spheroids and organoids in translational research. Master advanced techniques, such as microfluidics, 3D culture and live-cell 3D imaging, and discover through case studies how these models are able to transform disease modeling, drug screening, and the development of personalized treatments.

Hematology is a continuously changing discipline virtuously standing half the way between the bench and the bed. It is continuously informed by advancements in genetics and pathophysiology that, at a sometimes incredible pace, translated into diagnostic, prognostic and therapeutic benefits for the patients.
The third edition of the Florence Symposium “From genes to targeted therapy in hematology” will host international KOL presenting the latest news in oncologic and non-oncologic hematologic diseases with the aim to boost knowledge and interactions among participants.

Following the success of the first European Cancer Dependency Map Symposium in 2023, we are excited to announce the 2nd edition, to be held at Human Technopole. The event aims to convene world-leading experts in the fields of functional genomics and genome-editing screens to advance the discovery of new cancer vulnerabilities and therapeutic targets. It will also serve as a valuable platform for early-career researchers to engage with cutting-edge developments and foster scientific exchange. A new feature of this year’s programme is a dedicated segment on AI tools and advanced computational approaches.

The agenda includes talks by renowned scientists, an extended panel discussion with experts from industry and an editor from Nature Genetics, as well as three short poster sessions. Participants are warmly encouraged to submit an abstract for a chance to present their work.

The 2nd Cancer Dependency Map Symposium represents a great opportunity within the Italian and the international research landscape to explore the latest breakthroughs and gain insights into the future of the systematic identification of tumour vulnerabilities.